SEC Filings

Filing date Form Description Filing Group View
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
8-K

Report of unscheduled material events or corporate event

Current Reports
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
8-K

Report of unscheduled material events or corporate event

Current Reports
CT ORDER

CT ORDER

Other
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
4/A

Amendment to a previously filed 4

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
8-K

Report of unscheduled material events or corporate event

Current Reports

Footer disclaimer

Footer disclaimer

© Natera 2019. All Rights Reserved. The tests described on this site were developed by Natera, Inc. a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). The tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests.